Cspc Zhongqi Pharmaceutical Technology Co., Ltd.

This study is testing an investigational antibody injection called CM326 for people with moderate-to-severe chronic obstructive pulmonary disease (COPD). The main goal is to see if the injection can reduce the number of serious symptom flare-ups (called exacerbations) and improve…

This study is testing the safety and effectiveness of a new drug, glumetinib, combined with a chemotherapy drug (docetaxel) for people with advanced stomach, gastroesophageal junction, or other solid tumors that have a specific genetic feature called MET overexpression/amplificat…

This study is testing whether combining two existing drugs works better than current options for advanced neuroendocrine tumors of the gut and pancreas. It's for patients whose cancer has spread and who have not yet received any systemic cancer treatment. The main goals are to se…

This trial is testing whether combining a drug called sirolimus with several newer antibody-drug conjugates (ADCs) is safe and effective for people with advanced solid tumors that have spread or can't be removed by surgery. Researchers will enroll about 444 patients to find the b…

This is an early safety study for a new, unnamed drug called SYH2085. Researchers are testing it in healthy Chinese volunteers to see if it is safe, what side effects it might have, and how the body absorbs and processes it. The study will also check if eating food affects how th…